miR-186 in Alzheimer's disease: a big hope for a small RNA?

    loading  Checking for direct PDF access through Ovid


This Editorial highlights a study by Kim et al. in the current issue of Journal of Neurochemistry, in which the authors demonstrate that miR-186 is a potent negative regulator of BACE1 and might be one of the molecular links between advanced brain aging and the increased risk for Alzheimer disease.

Read the highlighted article‘miR-186 is decreased in aged brain and suppresses BACE1 expression’ on page 436.

Related Topics

    loading  Loading Related Articles